Table 1 Characteristics and descriptive information for the sample (N = 49)

Sex; men/women, n (%)

27 (55)/22 (45)

Age (years), mean (SD)

65 (7)

PD duration (years), median (q1–q3)

4.3 (1.9–7.1)

PD severity (H&Y), median (q1–q3)

2 (2–2)

Motor symptoms (UPDRS III), median (q1–q3)^a

14 (7–19)

Cognitive impairments (MoCA), median (q1–q3)

28 (27–29)

Body mass index (kg/m²), mean (SD)

26.8 (4.6)

Physical capacity (6-min walk test; meters), mean (SD)

451 (109)

Comorbidity, self-reported (yes), n (%)

22 (45) ^b

 Heart and vascular disease, n (%)

10 (20)

 Goiter/hypothyroidism, n (%)

3 (6)

 Osteoarthritis, n (%)

4 (8)

 Pulmonary disease, n (%)

3 (6)

 Disease in gastrointestinal or bladder function, n (%)

3 (6)

 Diabetes, n (%)

1 (2)

 Inguinal hernia, n (%)

1 (2)

Using walking aid indoors, n (%)

5 (10)

Using walking aid outdoors, n (%)

12 (24)

Freezing of gait (scoring ≥1 on item 3 of the FOGQsa), n (%)

17 (35)

Falls in the past 6 months, n (%)

10 (20)

 Sedentary time (min/day), median (q1–q3)^d

598 (534–670)

 Light PA (min/day), median (q1–q3)^e

166 (112–214)

 Lifestyle PA (min/day), median (q1–q3)^f

31 (21–51)

 Moderate PA (min/day), median (q1–q3)^g

10 (2–20)

 Vigorous PA (min/day), median (q1–q3)^h

0 (0–0)

 Very vigorous PA (min/day), median (q1–q3)ⁱ

0 (0–0)